Ranjit C Singh

CIK 1251440 · last filed 2014-08-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$493.2K

Companies

Total Filings

Lifetime Open-Market Net

-$227.1K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

ULBI price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ULBI	Director	79,801	$6.18	$493.2K	-$227.1K	32	2014-08-18
Aeon Global Health Corp. (PRCP) Delisted	Director	70,556	—	—	$0	19	2011-04-19

Recent Filings · Page 3 of 6

51 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2010-02-09	Aeon Global Health Corp. (PRCP) Delisted	Grant (A)	+3,095	$3.2K	EDGAR
2009-12-29	ULBI	Mixed	+2,001	$7.4K	EDGAR
2009-11-24	ULBI	Mixed	+3,918	-$983	EDGAR
2009-11-17	ULBI	Grant (A)	+2,529	$0	EDGAR
2009-11-03	Aeon Global Health Corp. (PRCP) Delisted	Grant (A)	+2,837	$4.0K	EDGAR
2009-09-03	Aeon Global Health Corp. (PRCP) Delisted	Grant (A)	—	$0	EDGAR
2009-08-17	ULBI	Grant (A)	+1,553	$0	EDGAR
2009-05-15	ULBI	Grant (A)	+1,402	$0	EDGAR
2009-02-10	Aeon Global Health Corp. (PRCP) Delisted	Grant (A)	+18,750	$91.41M	EDGAR
2008-12-30	ULBI	Exer (M)	—	$0	EDGAR

Showing 21–30 of 51

Prev Page 3 of 6 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.